Dr Reddy’s gets US FDA approval for rituximab biosimilar; Fresenius Kabi to commercialise product

Dr Reddy’s received US FDA approval for its rituximab biosimilar, expanding its US market presence. Fresenius Kabi will commercialize it.

Leave a Reply

Your email address will not be published. Required fields are marked *